Instituto de Salud Global de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2024

  1. Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists

    Endocrinologia, Diabetes y Nutricion, Vol. 71, Núm. 4, pp. 149-151

2021

  1. Non-alcoholic fatty liver disease: A patient guideline

    JHEP Reports, Vol. 3, Núm. 5